CINECA IRIS Institutional Research Information System

BERARDELLI, RITA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.341
AS - Asia 1.704
EU - Europa 1.495
SA - Sud America 205
AF - Africa 35
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.797
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.262
SG - Singapore 690
CN - Cina 506
SE - Svezia 240
IT - Italia 197
DE - Germania 171
BR - Brasile 159
VN - Vietnam 159
UA - Ucraina 150
FI - Finlandia 146
IE - Irlanda 146
FR - Francia 135
KR - Corea 83
PL - Polonia 63
GB - Regno Unito 58
CA - Canada 56
JP - Giappone 45
IN - India 44
NL - Olanda 44
HK - Hong Kong 27
AT - Austria 26
RU - Federazione Russa 21
TR - Turchia 21
PH - Filippine 20
AR - Argentina 19
BE - Belgio 18
ID - Indonesia 17
MX - Messico 17
DK - Danimarca 16
GR - Grecia 15
AU - Australia 14
UZ - Uzbekistan 13
ES - Italia 11
IQ - Iraq 11
BD - Bangladesh 10
PK - Pakistan 10
EC - Ecuador 8
LB - Libano 8
SA - Arabia Saudita 8
ZA - Sudafrica 8
EG - Egitto 7
MA - Marocco 7
LT - Lituania 6
PT - Portogallo 6
TW - Taiwan 6
IR - Iran 5
RS - Serbia 5
CH - Svizzera 4
CO - Colombia 4
NP - Nepal 4
RO - Romania 4
TN - Tunisia 4
UY - Uruguay 4
JO - Giordania 3
NG - Nigeria 3
VE - Venezuela 3
CL - Cile 2
CY - Cipro 2
GY - Guiana 2
HN - Honduras 2
HR - Croazia 2
JM - Giamaica 2
LV - Lettonia 2
MY - Malesia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PE - Perù 2
QA - Qatar 2
SI - Slovenia 2
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
GA - Gabon 1
GT - Guatemala 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
MK - Macedonia 1
MT - Malta 1
PY - Paraguay 1
SD - Sudan 1
SN - Senegal 1
SV - El Salvador 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.797
Salva come PNG Salva come JPEG
Città #
Singapore 420
Chandler 397
Beijing 334
San Jose 280
Ashburn 248
Santa Clara 221
Houston 219
Dublin 146
Dearborn 113
Ann Arbor 109
Fairfield 77
Jacksonville 68
Wilmington 68
Nyköping 66
Munich 57
Torino 54
Princeton 48
Helsinki 46
Los Angeles 46
Warsaw 45
Columbus 43
Villeurbanne 43
Lauterbourg 40
Medford 39
New York 39
Woodbridge 39
Seattle 38
Ho Chi Minh City 36
The Dalles 35
Buffalo 30
Redwood City 30
Hanoi 29
Pisa 29
Toronto 29
Boston 28
Cambridge 27
Vienna 25
Fremont 22
Hong Kong 22
Tokyo 22
Guangzhou 20
San Mateo 19
Ankara 16
Dallas 16
Düsseldorf 16
Frankfurt am Main 16
Boardman 15
Brussels 15
Dong Ket 15
Turku 14
Chicago 13
Milan 13
Rome 13
São Paulo 13
Jakarta 12
Chennai 11
Norwalk 11
Council Bluffs 10
Nanjing 10
Amsterdam 9
London 9
Orem 9
Portland 9
Washington 9
Kunming 8
Nuremberg 8
Phoenix 8
Hefei 7
Shanghai 7
Silver Spring 7
Baghdad 6
Brooklyn 6
Falkenstein 6
Hangzhou 6
Mumbai 6
Paris 6
Poznan 6
Athens 5
Belgrade 5
Belo Horizonte 5
Brisbane 5
Charlotte 5
Curitiba 5
Denver 5
Mexico City 5
Osaka 5
Pune 5
San Diego 5
San Francisco 5
Seoul 5
Stockholm 5
Taipei 5
Barcelona 4
Da Nang 4
Dhaka 4
Durham 4
Falls Church 4
Guayaquil 4
Haiphong 4
Jinan 4
Totale 4.214
Salva come PNG Salva come JPEG
Nome #
CUSHING'S SYNDROME IS ASSOCIATED WITH SLEEP ALTERATIONS DETECTED BY WRIST ACTIGRAPHY 467
BCLI POLYMORPHISM OF THE GLUCOCORTICOID RECEPTOR GENE IS ASSOCIATED WITH INCREASED OBESITY, IMPAIRED GLUCOSE TOLERANCE AND DYSLIPIDEMIA IN PATIENTS WITH ADDISON’S DISEASE 426
ACUTE ADMINISTRATION OF ALPRAZOLAM, A BENZODIAZEPINE ACTIVATING GABA RECEPTORS, INHIBITS CORTISOL SECRETION IN PATIENTS WITH SUBCLINICAL BUT NOT OVERT CUSHING'S SYNDROME 343
Enhanced oxidative stress and platelet activation in patients with Cushing's syndrome. 324
IMPROVEMENT OF ANTHROPOMETRIC AND METABOLIC PARAMETERS, AND QUALITY OF LIFE FOLLOWING TREATMENT WITH DUAL-RELEASE HYDROCORTISONE IN PATIENTS WITH ADDISON'S DISEASE 267
Neuroendocrine effects of citalopram, a selective serotonine re-uptake inhibitor, during life span in humans 209
ROLE OF MINERALOCORTICOID RECEPTORS ON HPA AXIS IN HUMANS 175
THE ACUTE EFFECT OF FLUDROCORTISONE ON BASAL AND HCRH-STIMULATED HYPOTHALAMIC-PITUITARY-ADRENAL (HPA) AXIS IN HUMANS 173
Secondary adrenal insufficiency: Where is it hidden and what does it look like? 172
Effect of acute and prolonged mineralocorticoid receptor blockade on spontaneous and stimulated hypothalamus-pituitary-adrenal (HPA) axis in humans 160
DUAL-RELEASE HYDROCORTISONE IN ADDISON’S DISEASE-A REVIEW OF THE LITERATURE 160
GLUCOCORTICOID RECEPTOR POLYMORPHISMS AND METABOLIC-CARDIOVASCULAR PROFILE IN PATIENTS WITH ADDISON’S DISEASE UNDER REPLACEMENT THERAPY 151
METABOLIC AND CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT ETIOLOGY BEFORE AND 1 YEAR AFTER DISEASE REMISSION 151
EFFECTS OF CETRORELIX, A GnRH-RECEPTOR ANTAGONIST, ON GONADAL AXIS IN WOMEN WITH FUNCTIONAL HYPOTHALAMIC AMENORRHEA 149
Ghrelin, hypothalamus-pituitary-adrenal (HPA) axis and Cushing's syndrome 142
EFFECTS OF GNRH-RECEPTOR BLOCKADE ON GONADAL AXIS IN WOMEN WITH FUNCTIONAL HYPOTHALAMIC AMENORRHEA 141
THE ACUTE EFFECT OF A MINERALOCORTICOID RECEPTOR AGONIST ON CORTICOTROPE SECRETION IN ADDISON'S DISEASE 140
METABOLIC AND CARDIOVASCULAR PROFILE IN PATIENTS WITH ADDISON’S DISEASE UNDER CONVENTIONAL GLUCOCORTICOID REPLACEMENT 137
EFFECT OF PROLONGED TREATMENT WITH POTASSIUM CANRENOATE, A MR ANTAGONIST, ON BASAL AND STIMULATED HYPOTHALAMUS-PITUITARY-ADRENAL (HPA) AXIS IN HUMANS 136
NEUROENDOCRINE EFFECTS OF CITALOPRAM, A SELECTIVE SEROTONIN RE-UPTAKE INHIBITOR (SSRI), DURING LIFESPAN IN HUMANS 133
THE INHIBITORY EFFECT OF FLUDROCORTISONE ON HPA AXIS IS NOT ONLY EXERTED THROUGH HIPPOCAMPAL MR RECEPTORS: POSSIBLE CLINICAL IMPLICATIONS 132
METABOLIC AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT AETIOLOGY DURING ACTIVE DISEASE AND 1 YEAR AFTER REMISSION 132
Metabolic and cardiovascular profile in patients with Addison's disease under conventional glucocorticoid replacement 128
PATIENTS WITH AUTOIMMUNE DISEASES SHOWED ENHANCED BASAL AND STIMULATED CORTICOTROPH SECRETION 127
CONVENTIONAL GLUCOCORTICOID REPLACEMENT THERAPY IN PATIENTS WITH ADDISON’S DISEASE: EFFECT ON METABOLIC AND BONE PARAMETERS 125
Retrospective observational analysis of non-irradiated non-functioning pituitary adenomas 124
HORMONAL, METABOLIC AND BONE EVALUATION IN A SERIES OF ADRENAL INCIDENTALOMAS 123
WRIST ACTIGRAPHY DOES NOT REVEAL SLEEP DISTURBANCES IN PATIENTS WITH ADDISON’S DISEASE UNDER CONVENTIONAL GLUCOCORTICOID REPLACEMENT THERAPY 123
COMPARISON BETWEEN ITT, METYRAPONE AND ACTH STIMULATION WITH HIGH, LOW AND VERY LOW DOSES FOR DIAGNOSIS OF SECONDARY HYPOADRENALISM 121
Long-term morphological, hormonal and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas 120
Neuroregulation of the hypothalamus-pituitary-adrenal (Hpa) axis in humans: effects of Gaba-, mineralcortoid-, and gh-secretagogue-receptor modulation 118
Hypothalamus-pituitary-adrenal axis evaluation in patients with hypothalamo-pituitary disorders: comparison of different provocative test 116
NEUROENDOCRINE EFFECT OF CITALOPRAM, A SELECTIVE SEROTONIN RE-UPTAKE INHIBITOR (SSRI), IN ANOREXIA NERVOSA 111
LONG-TERM MORPHOLOGICAL AND HORMONAL FOLLOW-UP IN A SERIES OF 124 ADRENAL INCIDENTALOMAS 110
EFFECTS OF CORTISTATIN-17 AND SOMATOSTATIN-14 ON ACTH AND CORTISOL HYPERSECRETION IN PATIENTS WITH CUSHING’S DISEASE 110
COMPARISON BETWEEN CORTISOL AND DEXAMETHASONE NEGATIVE FEEDBACK ACTION IN HUMANS 109
Tyrosine kinase inhibitors rechallenge in solid tumors: a review of literature and a case description with lenvatinib in thyroid cancer 105
Enhanced oxidative stress and platelet activation combined with reduced antioxidant capacity in obese prepubertal and adolescent girls with full or partial metabolic syndrome. 104
Corticotrope hypersecretion coupled with cortisol hypo-responsiveness to stimuli is present in patients with autoimmune endocrine disease: evidence for subclinical primary hypoadrenalism? 104
EFFECTS OF GHRELIN ON HYPOTHALAMO-PITUITARY-ADRENAL AXIS IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT ETIOLOGY 102
Neuroendocrine effects of citalopram, a selective serotonin re-uptake inhibitor (SSRI), in anorexia nervosa. 101
SECONDARY ADRENAL INSUFFICIENCY: WHERE IT IS HIDDEN AND HOW IT LOOKS 97
Lenvatinib in advanced radioiodine-refractory thyroid cancer: A snapshot of real-life clinical practice 97
Insulin and GH-IGF-I axis: endocrine pacer or endocrine disruptor? 95
WRIST ACTIGRAPHY REVEALS SLEEP DISTURBANCES IN PATIENTS WITH CUSHING’S DISEASE 78
Totale 6.968
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.213
article - articoli 0
book - libri 0
conference - conferenze 7.069
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.282
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202159 0 0 0 0 0 0 0 0 0 0 0 59
2021/2022612 14 12 15 49 40 24 78 42 26 85 124 103
2022/2023905 89 89 28 114 71 233 46 52 96 32 38 17
2023/2024327 55 55 27 16 17 52 5 14 2 18 19 47
2024/20251.007 1 71 38 95 276 65 13 59 126 44 78 141
2025/20261.875 276 39 105 193 230 148 332 58 170 223 83 18
Totale 6.968